Reacción #161864

ord-64b68e5cee0f44239a57c62f5c0835a7

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThen the reaction mixture was purified by preparative HPLC-MS
  2. 2
    Otrofreeze-dried

Procedimiento

125 mg (0.43 mmol) (4-chloro-6-methyl-pyridin-2-yl)-(5-fluoro-2,3-dihydro-indol-1-yl)-methanone, 118 mg (0.43 mmol) 7-methoxy-3-piperidin-4-yl-1,3,4,5-tetrahydro-1,3-benzodiazepin-2-one and 89 mg (0.65 mmol) potassium carbonate in 2.0 mL NMP were stirred for 10 h at 130° C. Then the reaction mixture was purified by preparative HPLC-MS. The product-containing fractions were combined and freeze-dried.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US08829006B2uspto-grants-2014_09